Levels
Levels is a Continuous Glucose & Metabolic company founded in 2019 and based in New York, United States. It has raised $50M in total funding, most recently a Series A extension in 2024.
Founded in 2019, Levels builds a metabolic-health software layer on top of continuous glucose monitors (CGMs), translating real-time glucose data into personalized insights about how food, exercise, sleep, and stress affect a user's blood sugar. The company raised a $38M Series A in 2022 at a roughly $300M valuation, followed by a $10M Series A extension in 2024 backed by Andreessen Horowitz, taking total funding to around $50M. Co-founders include Sam Corcos (CEO), Casey Means MD, and Josh Clemente. Levels markets to the non-diabetic wellness and prediabetes audience seeking to optimize metabolic fitness.
Levels helped define the consumer metabolic-health category, turning prescription CGM hardware into a wellness software subscription for non-diabetics.
levels.com ↗·Continuous Glucose & Metabolic·
United States·private 
